Bahrain approves Pfizer/BioNTech virus vaccine as 2nd country
Published: 01:18 PM, 5 December 2020
Bahrain announced on Friday that it had approved the emergency use of the Pfizer-BioNTech COVID vaccine, becoming the second country after the UK to give a green signal for the drug.
The approval of the Pfizer/BioNTech vaccine will add a further important layer to the kingdom’s national Covid-19 response, reports Bahrain News Agency (BNA), quoting the statement of Mariam al-Jalahma, CEO of the National Health Regulatory Authority.
However, Mariam al-Jalahma did not specify when it would begin the rollout of the vaccine by US pharmaceutical giant Pfizer and its German partner BioNTech.
“This authorization is a goal we have been working toward since we first declared that science will win,” said Lindsey Dietschi, Pfizer representative in the Gulf, the BNA reported.
The United Kingdom on Wednesday said it approved the Covid-19 vaccine for general use, with plans to start rolling it out next week.
Britain insisted Friday its world-first approval of the Pfizer-BioNTech coronavirus vaccine met all safety standards, striving to tamp down any public unease after US and European officials queried the rapid process.
Bahrain, in November, approved the use of China’s Sinopharm vaccine for frontline healthcare workers. The country has so far recorded more than 87,000 novel coronavirus cases, including 341 deaths.